Back
Back
DORA and LP
Official Title
Effect of a Dual Orexin Receptor Antagonist on Alzheimer's Disease Biomarkers
Study Details
The purpose of the study is to see if an investigational treatment will decrease proteins in the blood & spinal fluid that are associated with Alzheimer's.
Principal Investigator
Dr. Brendan Lucey
IRB Number
202301150
Eligibility
1. Participants must be at least 65 years old
2. Participants must not have sleep disorders
3. Participants must have a body mass index (BMI) less than 35
Compensation is provided (contact the study team for compensation amount).
This study accepts healthy volunteers.
Volunteer Information
For more information about this study, contact Volunteer for Health at:
- 314.362.1000
- rprstaff@wustl.edu